Keros Therapeutics Inc. CEO Jasbir Seehra told BioWorld that he plans to use at his new company lessons learned as co-founder of Acceleron Pharma Inc., where work with receptors in the TGF-beta superfamily “taught me the potential of the biology and those molecules, but also the limitations” with regard to safety that need to be surmounted.
San Francisco-based startup Element Science Inc. has raised a massive financing in support of the first product that is part of its next-generation digital wearable platform. The $145.6 million series C financing is slated to support the company through clinical trial completion and commercial launch of its Jewel Patch Wearable Cardioverter Defibrillator.
PERTH, Australia – Australian medication adherence technology firm Adherium Ltd. is relaunching itself after a management reshuffle and a successful capital raise of AU$5.4 million (US$3.5 million) to deploy a new commercial strategy.
Biopharmas raising money in public or private financings, including: Akouos, Emmaus Life Sciences, Lipidio Pharmaceuticals, Pliant Therapeutics, Xortx Therapeutics.